Submission of Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Samir Dilipkumar Shah, Promoter and Managing Director of Medico Intercontinental Ltd, acquired 1,97,285 equity shares through an open market purchase on 24th December 2025. Post this acquisition, his shareholding in the company increased from 44,42,828 shares (44.43%) to 46,40,113 shares (46.40%), a rise of about 1.97 percentage points. The disclosure was filed under SEBI's Prohibition of Insider Trading Regulations to report the insider trade.
This signals promoter confidence in the company, as the Managing Director personally bought shares from the open market. The increased promoter stake may be viewed positively by retail investors as it indicates insider belief in future growth.